No abstract available
MeSH terms
-
Agranulocytosis / prevention & control*
-
Antineoplastic Combined Chemotherapy Protocols / adverse effects
-
Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
-
Carcinoma, Transitional Cell / drug therapy*
-
Cisplatin / administration & dosage
-
Colony-Stimulating Factors / therapeutic use*
-
Colony-Stimulating Factors / toxicity
-
Doxorubicin / administration & dosage
-
Drug Evaluation
-
Granulocyte Colony-Stimulating Factor
-
Humans
-
Methotrexate / administration & dosage
-
Neoplasms / drug therapy*
-
Neutropenia / etiology
-
Neutropenia / prevention & control*
-
Neutrophils / cytology
-
Neutrophils / drug effects
-
Recombinant Proteins / therapeutic use*
-
Recombinant Proteins / toxicity
-
Vinblastine / administration & dosage
Substances
-
Colony-Stimulating Factors
-
Recombinant Proteins
-
Granulocyte Colony-Stimulating Factor
-
Vinblastine
-
Doxorubicin
-
Cisplatin
-
Methotrexate